Lars Ståhle
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Virology top 5%
Papers in
-
- Pharmacological Effects and Toxicity Studies 16
- Oncology 12
- Drug Transport and Resistance Mechanisms 10
- Co-authors
- Svante Wold (3 shared papers)Urban Ungerstedt (9 shared papers)Ingemar Björkhem (3 shared papers)Ulf Diczfalusy (2 shared papers)Dieter Lütjohann (2 shared papers)Robert Schvarcz (4 shared papers)Annette Bruchfeld (3 shared papers)G. Ahlborg (1 shared paper)
- Journals
- Therapeutic Drug Monitoring (9 papers)Pharmacology Biochemistry and Behavior (3 papers)Life Sciences (3 papers)Journal of Pharmaceutical Sciences (2 papers)Analytica Chimica Acta (2 papers)
- Partner nations
- SwedenUnited StatesGermany
In The Last Decade
Lars Ståhle
68 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 156
- Hepatology 353
- Virology 208
- Analytical Chemistry 251
- Cellular and Molecular Neuroscience 434
- Infectious Diseases 440
Countries citing papers authored by Lars Ståhle
This map shows the geographic impact of Lars Ståhle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Ståhle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Ståhle more than expected).
Fields of papers citing papers by Lars Ståhle
This network shows the impact of papers produced by Lars Ståhle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Ståhle. The network helps show where Lars Ståhle may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Ståhle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 439 | |
| 2 | 1987 | 406 | |
| 3 | 2005 | 169 | |
| 4 | 1988 | 159 | |
| 5 | 2006 | 146 | |
| 6 | 1991 | 140 | |
| 7 | 2010 | 137 | |
| 8 | 2000 | 126 | |
| 9 | 2002 | 113 | |
| 10 | 1991 | 109 | |
| 11 | 2003 | 86 | |
| 12 | 2005 | 85 | |
| 13 | 1992 | 79 | |
| 14 | 2003 | 76 | |
| 15 | 2012 | 75 | |
| 16 | 1987 | 73 | |
| 17 | 1991 | 61 | |
| 18 | 1984 | 61 | |
| 19 | 1999 | 58 | |
| 20 | 2006 | 55 |
About Lars Ståhle
Lars Ståhle is a scholar working on Pediatrics, Perinatology and Child Health, Oncology, Infectious Diseases, Pharmacology and Epidemiology, having authored 68 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (16 papers), HIV/AIDS drug development and treatment (10 papers), Drug Transport and Resistance Mechanisms (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Epilepsy research and treatment (8 papers), Neurotransmitter Receptor Influence on Behavior (6 papers), Cytomegalovirus and herpesvirus research (6 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Hepatology (353 citations), Virology (208 citations), Analytical Chemistry (251 citations), Cellular and Molecular Neuroscience (434 citations) and Infectious Diseases (440 citations). Lars Ståhle has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Svante Wold, Urban Ungerstedt, Ingemar Björkhem, Ulf Diczfalusy, Dieter Lütjohann, Robert Schvarcz, Annette Bruchfeld, G. Ahlborg, John Wahren and Karin Lindahl. Their work appears in journals such as Therapeutic Drug Monitoring, Pharmacology Biochemistry and Behavior, Life Sciences, Journal of Pharmaceutical Sciences and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.